key: cord-0760304-xpklpzow authors: Sundberg, Emil; Georgantzi, Kleopatra; Langenskiöld, Cecilia; Król, Ladislav; Nilsson, Frans; Vogt, Hartmut; Palle, Josefine; Ek, Torben; Nilsson, Anna title: Low numbers of COVID‐19 in Swedish pediatric oncology patients during the first pandemic year despite an open society date: 2022-04-29 journal: Pediatr Blood Cancer DOI: 10.1002/pbc.29750 sha: 6941a09cba425a56a2b4ad2ba5cbe3cbfccb17e4 doc_id: 760304 cord_uid: xpklpzow BACKGROUND: Sweden adopted a different strategy than many other countries to combat the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) pandemic and kept most schools open. Initial reports from China suggested that coronavirus disease 2019 (COVID‐19) was milder in children compared to adults, but there was a lack of data from immunocompromised children. Therefore, we investigated the rate of verified SARS‐CoV‐2 infections in our Swedish pediatric oncology patients. PROCEDURE: This was a multicenter retrospective study. A questionnaire including patient data as well as SARS‐CoV‐2 data was sent to the six Swedish childhood cancer centers in May 2021. RESULTS: During the first pandemic year, 49 patients were identified as SARS‐CoV‐2 positive, and 22 (45%) children were hospitalized with COVID‐19. Two children needed intensive care, but no COVID‐19‐related deaths were reported. Most patients (n = 36, 73%) were on active chemotherapy treatment and 23 children (49%) attended school or daycare at least part‐time. Half of the SARS‐CoV‐2‐positive patients experienced a delay in cancer treatment. CONCLUSIONS: Despite the rapid spread of SARS‐CoV‐2 in Sweden, without a strict lockdown of the society, the number of nationally reported pediatric oncology patients with polymerase chain reaction (PCR)‐verified infection was low, and the majority of children had mild disease. Our data show that treatment interruptions occurred frequently and this should clearly be avoided for the coming years. In late 2019, the first cases of atypical pneumonia were reported from Wuhan, China. Within a few months, the spread of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was declared a global pandemic, and significant morbidity and mortality in high-risk populations were reported due to the associated coronavirus disease 2019 (COVID-19). 1 As of the end of September 2021, 232 million cases and almost 5 million deaths have been reported globally. Early in the pandemic, in the absence of effective testing strategies, treatment or prevention by vaccines, countries applied different strategies to limit virus spread. Many regions around the world went into strict lockdown for all age groups and it is estimated that the resulting school closures have affected >90% of students globally. In contrast, Sweden adopted a different approach to contain the virus, and chose to keep schools and daycare facilities open for children, except for a 3-month school closure for students >16 years of age starting in March 2020. 2 The adult population was encouraged to work from home, practice social distancing, and adhere to common hygiene measures. Initially, Sweden reported higher case counts and attributable mortality than other Nordic countries, but lower compared to other European countries. 3 Children were in general reported to experience asymptomatic infection or to have milder disease than adults. 4 Early reports from China suggested that adult oncology patients were at higher risk of severe COVID-19 than patients without cancer. 5 Encouraging early data from Italy suggested that despite their immunosuppressed state, children with cancer may have a benign, self-limiting disease. 6 This was further supported by a global flash survey including 25 countries, reporting asymptomatic/mild COVID-19 in eight of nine polymerase chain reaction (PCR)-confirmed cases. 7 A meta-analysis of COVID-19 data from pediatric oncology patients compiled in June 2020 also showed a low COVID-related mortality of 0.6%, with no difference in the risk of hospitalization between children with hematological malignancies or solid tumors. 8 During the second year of the pandemic, more data have been available on the impact of COVID-19 for pediatric oncology. A recent report from the United States on the New York-New Jersey regional experience covering 13 institutions, showed that while most pediatric oncology patients with PCR-verified COVID-19 experienced asymptomatic or mild disease, they suffered a higher morbidity than reported for the general pediatric population. 9 A major concern highlighted by this study is the high risk for delays in chemotherapy that accompanies COVID-19. In Sweden, children with cancer are diagnosed at one of six childhood cancer centers located at the regional university hospitals in In this report, we present national data on COVID-19 cases in pediatric oncology patients from Sweden; a country that adopted a different strategy than many other countries to combat the pandemic by never implementing a full lockdown and keeping schools mostly open. We report on the geographic and demographic distribution of COVID-19 cases and on the clinical outcomes observed in this patient cohort, including observed treatment delays. In Sweden, most children with cancer (except for those who have received a stem cell transplant) and their families are recommended to participate in normal age-appropriate activities as long as the child is in a general good condition, despite treatment effects such as neutropenia, thrombocytopenia, and other stress factors. This strategy is supported by a Swedish study that reported that children undergoing oncological treatment and attending school did not suffer an increased risk of starting antimicrobial treatment, compared to those who did not attend school. 10 During the pandemic, it was recommended by the Supportive Care Group 11 that most children with cancer should follow the general recommendations for children provided by the PHA. Local exceptions existed and included the Gothenburg region, where physicians were cautious during the first 3-6 months of the pandemic and recommended daycare/school absence for patients who were in the intensive treatment phase of hematological malignancies. In Stockholm and Lund, all asymptomatic patients were tested for active SARS-CoV-2 infection before admission to the ward or before anesthesia for procedures, and children with fever or respiratory symptoms were tested as part of diagnostic workup. In Gothenburg, symptomatic patients and patients scheduled for anesthesia were tested during the first and second waves. In Linköping and Uppsala, only children with upper respiratory symptoms were tested for SARS-CoV-2, while asymptomatic children were admitted without testing. In Umeå, only patients with respiratory symptoms were tested for SARS-CoV-2 during the first pandemic wave, while all patients and their parents were tested before admission during the second wave. In general, asymptomatic staff were not routinely tested for active SARS-CoV-2 infection, but were required to wear face masks at all patient contacts and at staff meetings, when unable to keep a 2-m distance. In Table 1 . Almost half of the children were attending school or daycare at least part-time, despite the pandemic. COVID-19 cases in pediatric cancer patients in the first wave were observed primarily in the Stockholm area and more cases were identified in other parts of the country during the second wave ( Figure 1 ). Of the 49 SARS-CoV-2-positive patients, 22 children were hospitalized due to COVID-19 (Table 2 ). There were no differences in age between During the first SARS-CoV-2 pandemic year, Sweden adopted a different COVID-19 strategy than, for example, most of Europe and the were younger children. However, this most likely reflects the age distribution of childhood cancer rather than SARS-CoV-2 epidemiology, as many of our patients were tested before admission to the ward or before procedures involving anesthesia, and not as outpatients, as in the PHA report mentioned above. Ag testing in our cohort. Ag testing reliably detects samples with high viral loads, although it is not as effective in detecting low viral loads, whereas PCR also may differentiate between negative and low viral load samples. 15 As asymptomatic children tend to present with quite low viral loads, the number of asymptomatic SARS-CoV-2-positive children reported in this study may in part be explained by the aforementioned fact that many centers screened children using PCR rather than with Ag tests. The difference between positive cases among the Swedish pediatric cancer centers may rather be attributed to different testing strategies in combination with the fact that Swedish regions were affected differently between the first and second pandemic waves than different test methods. Although most children presented with mild symptoms, almost 50% were hospitalized due to COVID-19. In a few cases, hospitalization was required due to cancer treatment rather than the infection. The high rate of hospitalization observed in this study may reflect the initial lack of knowledge on COVID-19 in immunocompromised children, thereby resulting in an overly cautious clinical approach, despite early reports, for example, from Italy, 6 indicating a mild clinical course in most pediatric hemato-oncology and transplanted patients. Other reports have claimed a higher incidence of ICU admittance (9%) or death (4%), something that is not reflected in our population. 16 Of the two children admitted to ICU, one was in cancer follow-up and had been without cancer treatment for many years. This patient showed typical signs of COVID-19, including respiratory failure requiring intubation and ventilator-assisted breathing. The previous malignancy had resulted in chronic respiratory insufficiency, which likely contributed to the severity of disease in this case. The second child, however, was suffering from a pre-existing large solid lung tumor, which most likely impacted the respiratory failure. There were no deaths due to severe COVID-19 during the study period, which is in accordance with data from a meta-analysis showing an overall COVID-19 mortality of 0.6% in children with cancer. 8 Recently, national Polish data also indicated that children with cancer have a low mortality risk related to SARS-CoV-2. 17 This study was supported by grants from Swedish Childhood Cancer Foundation (Anna Nilsson). We thank Jenna Anderson for excellent language editing as well as commenting on our manuscript. Anna Nilsson was the principal investigator, and responsible for the study design, data compilation and analysis, and writing the initial draft. Emil Sundberg, Kleopatra Georgantzi, Josefin Palle was responsible for regional data collection and Torben Ek were responsible for initial review and editing. Emil Sundberg, Kleopatra Georgantzi, Hartmut Vogt, Frans Nilsson, Ladislav Król, Cecilia Langenskiöld, and Torben Ek were responsible for regional data collection. All authors reviewed and approved the final version of the manuscript. The authors declare that there is no conflict of interest. The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions. Anna Nilsson https://orcid.org/0000-0001-5885-7101 World Health Organization. WHO Director-General's opening remarks on Member State Information Session on COVID-19 -14 The first eight months of Sweden's COVID-19 strategy and the key actions and actors that were involved Leveraging epidemiological principles to evaluate Sweden's COVID-19 response SARS-CoV-2 infection in children Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China Lessons after the early management of the COVID-19 outbreak in a pediatric transplant and hemato-oncology center embedded within a COVID-19 dedicated hospital in Lombardia, Italy. Estote parati Flash survey on severe acute respiratory syndrome coronavirus-2 infections in paediatric patients on anticancer treatment Survival and complications in pediatric patients with cancer and COVID-19: a meta-analysis Characterization of COVID-19 disease in pediatric oncology patients: the New York-New Jersey regional experience Does school attendance during initial cancer treatment in childhood increase the risk of infection? Pediatr Blood Cancer COVID-19: Updated recommendations for children with cancer and their families Open schools, COVID-19, and child and teacher morbidity in Sweden Public Health Agency of Sweden. Folkhälsomyndigheten Antal fall av covid-19 i Sverige på regionnivå. Accessed November 30 Our mission -to strengthen and develop public health Diagnostic accuracy of SARS-CoV-2 antigen detection test in children: a real-life study SARS-CoV-2 in childhood cancer in 2020: a disease of disparities COVID-19 in pediatric cancer patients is associated with treatment interruptions but not with short-term mortality: a Polish national study Global characteristics and outcomes of SARS-CoV-2 infection in children and adolescents with cancer (GRCCC): a cohort study Low numbers of COVID-19 in Swedish pediatric oncology patients during the first pandemic year despite an open society